Single molecule biochips

Single molecule biochips

Technology & Engineering Single molecule biochips   Acute Traumatic Coagulopathy, a term first coined by Queen Mary’s Karim Brohi in 2003, occurs when traumatic bleeding leads to abnormal blood clotting. The result is more severe bleeding, organ failure, and...
Controlled release of pain management drugs

Controlled release of pain management drugs

Technology & Engineering Controlled release of pain management drugs   Conventional drugs used to manage pain and inflammation suffer from a burst release issue – you get a large dose all in one go, which quickly fades. This means that patients with severe...
Using n-3 DPA-derived Resolvins for Cardiovascular Diseases

Using n-3 DPA-derived Resolvins for Cardiovascular Diseases

Biopharma Using n-3 DPA-derived Resolvins for Cardiovascular Diseases   A novel therapeutic strategy, using n-3 DPA-derived resolvins to treat or prevent cardiovascular disease. Circadian rhythms play a key role in regulating various physiological functions, including...
Restoring Erythropoiesis in Myelodysplastic Syndrome

Restoring Erythropoiesis in Myelodysplastic Syndrome

Biopharma Restoring Erythropoiesis in Myelodysplastic Syndrome   Researchers at QMUL and Université de Bretagne-Occidentale have developed a method of restoring erythropoiesis in a patient suffering from a SF3B1 mutant myelodysplastic syndrome, involving the...
Repurposing an anti-cancer agent to treat heart failure

Repurposing an anti-cancer agent to treat heart failure

Biopharma Repurposing an anti-cancer agent to treat heart failure   A novel method for the prevention and treatment of heart failure, using αvβ3- and αvβ5-integrin targeting agents. The method has been shown to promote normal cardiac angiogenesis, endothelial cell...